Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AIG heads into the final weeks before its November 3 earnings with a small but accelerating short book and a Street divided between patient bulls and cautious neutrals.
The most interesting tension this week is the divergence between analyst direction and price. Two of the three most recent analyst moves went against the stock. Morgan Stanley lowered its Equal-Weight target from $81 to $80 on October 6. Mizuho followed on October 7, trimming its Neutral target from $85 to $83. Against that, UBS raised its Buy target from $98 to $100, keeping the bullish case alive. The consensus mean target sits at $88.30, roughly 17% above AIG's close of $75.11. That gap is wide, but recent momentum suggests the Street is slowly walking estimates down rather than chasing the stock higher.
The bull case rests on improving P&C underwriting discipline, a 13% rise in net investment income to $881 million last year, and Convex gross written premiums compounding at 25% annually over three years. Bears counter that underwriting results from Convex and the EG acquisition remain a drag, buybacks have slowed, and AIG trades at a discount to peers that the company has not yet earned the right to close. On valuation, AIG trades at 8.7 times earnings and 0.88 times book, both cheap in isolation but arguably fair given the margin uncertainty. The forward earnings growth factor score is exceptional, ranking in the 97th percentile, though 30-day EPS momentum sits at just the 66th percentile and the 90-day reading drops to the 30th, suggesting consensus upgrades have not followed the optimistic long-range view.
Short interest is low but moving in a direction worth tracking. At 1.87% of the free float, AIG is not a heavily shorted name. But the position has grown 28% over the past month, from around 7.8 million shares in early September to 10.1 million now. That is a meaningful build in absolute terms, even if the percentage remains modest. The lending market is not remotely stressed: availability is essentially unconstrained, with more than 500 million shares available to borrow against roughly 10 million already lent out. Cost to borrow has ticked up to 0.41% from 0.28% two weeks ago, but that remains among the lowest levels in the market. The ORTEX short score of 31.4 is stable and sits in the lower third of the range, consistent with the low-conviction nature of the current short book. Options positioning has softened slightly. The put/call ratio of 1.29 is marginally below its 20-day average of 1.34, a modest shift toward calls rather than puts. Neither the options market nor the borrow market is signalling any unusual pressure.
The insider picture is muted. Executive Chair Peter Zaffino sold approximately $18 million worth of shares in August, all under a pre-arranged 10b5-1 plan. Planned sales carry far less signal than discretionary trades, but the 90-day net insider position is negative at roughly 237,000 shares sold. No open-market purchases have been filed recently. BlackRock remains the largest institutional holder at 9.4% of shares, and added around 2.3 million shares through September. Wellington Management holds 5.8% and added nearly two million shares through July. There are no 13D activist filers on the register.
Retail attention is ticking up. Wikipedia views for AIG are running almost two standard deviations above their 90-day norm, a sign of elevated interest that does not by itself carry a directional read but suggests the stock is attracting more eyes than usual heading into earnings.
After its August report, AIG fell nearly 3% on the day and a further 4% over the following week. The prior quarter produced a 1-day move of just 0.1%. With the next print due November 3, the key question into that date is whether underwriting margins at Convex and Global Personal Lines have stabilised enough to justify the gap between the current price and the Street's target, or whether the Street follows Mizuho and Morgan Stanley and keeps trimming.
See the live data behind this article on ORTEX.
Open AIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
